{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:09:20Z","timestamp":1789495760494,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":167,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"publisher","award":["70115737"],"award-info":[{"award-number":["70115737"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.lrr.2025.100522","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T02:41:17Z","timestamp":1750300877000},"page":"100522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pharmacokinetics and outcome of high-dose melphalan followed by autologous stem cell transplantation in dialysis-dependent patients with multiple myeloma"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9374-300X","authenticated-orcid":false,"given":"Rabea","family":"Mecklenbrauck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard M.W.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"B\u00e4hre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Brioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Ganser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian H.","family":"Heidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicitas","family":"Thol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lrr.2025.100522_bib0001","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma","volume":"335","author":"Attal","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.lrr.2025.100522_bib0002","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","article-title":"High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma","volume":"348","author":"Child","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.lrr.2025.100522_bib0003","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2204925","article-title":"Triplet therapy, transplantation, and maintenance until progression in myeloma","volume":"387","author":"Richardson","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"Supplement 1","key":"10.1016\/j.lrr.2025.100522_bib0004","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1182\/blood-2020-137575","article-title":"Upfront autologous hematopoietic stem-cell transplantation improves overall survival in comparison with bortezomib-based intensification therapy in newly diagnosed multiple myeloma: long-term follow-up analysis of the randomized phase 3 EMN02\/HO95 study","volume":"136","author":"Cavo","year":"2020","journal-title":"Blood"},{"issue":"33","key":"10.1016\/j.lrr.2025.100522_bib0005","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1200\/JCO.2010.30.8791","article-title":"Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the international myeloma working group","volume":"28","author":"Dimopoulos","year":"2010","journal-title":"JCO"},{"issue":"1","key":"10.1016\/j.lrr.2025.100522_bib0006","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0609.2005.00446.x","article-title":"Autologous stem cell transplantation in multiple myeloma: outcome in patients with renal failure","volume":"75","author":"Knudsen","year":"2005","journal-title":"Eur. J. Haematol."},{"issue":"6","key":"10.1016\/j.lrr.2025.100522_bib0007","doi-asserted-by":"crossref","DOI":"10.1080\/10428194.2020.1867725","article-title":"Renal insufficiency in multiple myeloma: a systematic review and meta-analysis of all randomized trials from 2005 to 2019","volume":"62","author":"Mohyuddin","year":"2021","journal-title":"Leuk. Lymphoma."},{"issue":"4","key":"10.1016\/j.lrr.2025.100522_bib0008","first-page":"205","article-title":"Induction therapy with novel agents and autologous stem cell transplant overcomes the adverse impact of renal impairment in multiple myeloma","volume":"1","author":"Kumar","year":"2019","journal-title":"Clin. Hematol. Int."},{"issue":"6A","key":"10.1016\/j.lrr.2025.100522_bib0009","first-page":"2379","article-title":"Pharmacokinetics of high-dose melphalan in adults: influence of renal function","volume":"14","author":"Kergueris","year":"1994","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.lrr.2025.100522_bib0010","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41409-023-01915-7","article-title":"Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients-the DIADEM study from the chronic malignancies working party of the EBMT","volume":"58","author":"Waszczuk-Gajda","year":"2023","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.lrr.2025.100522_bib0011","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41409-018-0122-8","article-title":"Extending autologous transplantation as first line therapy in multiple myeloma patients with severe renal impairment: a retrospective study by the SFGM-TC","volume":"53","author":"Augeul-Meunier","year":"2018","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.lrr.2025.100522_bib0012","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbmt.2017.08.031","article-title":"High-dose melphalan and stem cell transplantation in patients on dialysis due to immunoglobulin light-chain amyloidosis and monoclonal immunoglobulin deposition disease","volume":"24","author":"Batalini","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"10","key":"10.1016\/j.lrr.2025.100522_bib0013","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/sj.bmt.1704948","article-title":"Melphalan 200\u2009mg\/m2 with blood stem cell support as first-line myeloma therapy: impact of glomerular filtration rate on engraftment, transplantation-related toxicity and survival","volume":"35","author":"Carlson","year":"2005","journal-title":"Bone Marrow Transplant."},{"issue":"8","key":"10.1016\/j.lrr.2025.100522_bib0014","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.clml.2015.03.003","article-title":"Autologous hematopoietic stem cell transplantation in dialysis-dependent myeloma patients","volume":"15","author":"El Fakih","year":"2015","journal-title":"Clin. Lymphoma. Myeloma. Leuk."},{"issue":"10","key":"10.1016\/j.lrr.2025.100522_bib0015","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/bmt.2016.132","article-title":"Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis","volume":"51","author":"Lee","year":"2016","journal-title":"Bone Marrow Transplant."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221304892500024X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221304892500024X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T12:47:34Z","timestamp":1764852454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221304892500024X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":15,"alternative-id":["S221304892500024X"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2025.100522","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics and outcome of high-dose melphalan followed by autologous stem cell transplantation in dialysis-dependent patients with multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2025.100522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100522"}}